Hurley Stage I — Solitary or Multiple Abscesses
Isolated abscesses without sinus tracts or scarring mark the mildest Hurley stage.
- None: Tract presence (placeholder metric)
- Minimal: Scarring (placeholder metric)
- Axilla, groin: Typical sites (placeholder metric)
- ~68%: Prevalence (placeholder metric)
Clinical presentation of Stage I
Short placeholder covering solitary abscess presentation and diagnosis.
Early disease course
Short placeholder describing early recurrence patterns without tracts.
Hurley Stage II — Recurrent Abscesses with Sinus Tracts
Recurrent lesions with sinus tract formation and limited scarring define Stage II.
- Present: Tract presence (placeholder metric)
- Moderate: Scarring (placeholder metric)
- Separated: Lesion spacing (placeholder metric)
- ~28%: Prevalence (placeholder metric)
Sinus tract formation
Short placeholder describing tract formation mechanisms.
Recurrence and scarring
Short placeholder on recurrence intervals and localized scarring.
Hurley Stage III — Diffuse Interconnected Tracts
Diffuse involvement with interconnected tracts and abscesses across an entire region.
- Extensive: Tract presence (placeholder metric)
- Severe: Scarring (placeholder metric)
- Diffuse: Area involvement (placeholder metric)
- ~4%: Prevalence (placeholder metric)
Diffuse regional involvement
Short placeholder describing broad interconnected tract networks.
Severe functional impact
Short placeholder on mobility and quality-of-life impairment.
Scarring Extent Across Hurley Stages
Scar tissue accumulates progressively as tract burden rises through the stages.
- Minimal: Stage I scarring (placeholder metric)
- Moderate: Stage II scarring (placeholder metric)
- Severe: Stage III scarring (placeholder metric)
- Tract count: Driver (placeholder metric)
Scar tissue accumulation
Short placeholder on cumulative fibrosis mechanisms.
Monitoring scarring extent
Short placeholder on tracking scar progression over time.
Treatment Intensity by Hurley Stage
Management escalates from topical therapy to systemic and surgical intervention.
- Topical/IL: Stage I care (placeholder metric)
- Antibiotics: Stage II care (placeholder metric)
- Wide excision: Stage III care (placeholder metric)
- Biologics: Adjunct (placeholder metric)
Stepwise treatment escalation
Short placeholder outlining escalation from topical to surgical care.
Role of biologic therapy
Short placeholder on biologic use in advanced disease.